The connection between the CYP2D6 IM polymorphism and the various subtypes of CML based on the presence or lack of the Philadelphia chromosome is perplexing; additional research is required to investigate the IM pathway in Ph-ve and Ph+ve CML. Here, CYP2D6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.